Survival benefit of liver resection for Barcelona Clinic Liver Cancer stage B hepatocellular carcinoma. BJS 2017; 104: 1045-1052.
Published: 8th May 2017
Authors: H. Kim, S. W. Ahn, S. K. Hong, K. C. Yoon, H.‐S. Kim, Y. R. Choi et al.
Although transarterial chemoembolization is recommended as the standard treatment for Barcelona Clinic Liver Cancer stage B hepatocellular carcinoma (
The nationwide multicentre database of the Korean Liver Cancer Association was reviewed. Patients with
Among 887 randomly selected patients with
Treatment strategies that include liver resection offer a survival benefit compared with non‐surgical treatments for potentially resectable
You may also be interested in
Comparison of gaze behaviour of trainee and experienced surgeons during laparoscopic gastric bypass.
Authors: S. Erridge, H. Ashraf, S. Purkayastha, A. Darzi, M. H. Sodergren
Notes: Potential uses in training and assessment
Early versus late recurrence of intrahepatic cholangiocarcinoma after resection with curative intent.
Authors: X.‐F. Zhang, E. W. Beal, F. Bagante, J. Chakedis, M. Weiss, I. Popescu et al.
Notes: Early recurrence is bad news
Growth rates of pulmonary metastases after liver transplantation for unresectable colorectal liver metastases.
Authors: H. Grut, S. Solberg, T. Seierstad, M. E. Revheim, T. S. Egge, S. G. Larsen et al.
Notes: Immunosuppression may not accelerate growth
Impact of weight loss and eating difficulties on health‐related quality of life up to 10 years after oesophagectomy for cancer.
Authors: P. Anandavadivelan, A. Wikman, A. Johar, P. Lagergren
Notes: Associated with deterioration of HRQOL
Influence of national centralization of oesophagogastric cancer on management and clinical outcome from emergency upper gastrointestinal conditions.
Authors: S. R. Markar, H. Mackenzie, T. Wiggins, A. Askari, A. Karthikesalingam, O. Faiz et al.
Notes: Improves outcome of oesophageal perforation
Authors: K. Mohkam, O. Farges, E. Vibert, O. Soubrane, R. Adam, F.‐R. Pruvot et al.
Notes: Multi‐institutionally validated prognostic tool
Randomized clinical trial
Randomized clinical trial of hepatic resection versus radiofrequency ablation for early‐stage hepatocellular carcinoma. BJS 2017; 104: 1775-1784.
Authors: K. K. C. Ng, K. S. H. Chok, A. C. Y. Chan, T. T. Cheung, T. C. L. Wong, J. Y. Y. Fung et al.
Notes: Radiofrequency ablation is not superior
Meta‐analysis of microsatellite instability in relation to clinicopathological characteristics and overall survival in gastric cancer.
Authors: K. Polom, L. Marano, D. Marrelli, R. De Luca, G. Roviello, V. Savelli et al.
Notes: Microsatellite instability subgroup does better
Authors: V. Wanjura, E. Szabo, J. Österberg, J. Ottosson, L. Enochsson, G. Sandblom et al.
Notes: Avoid unnecessary surgery
Authors: J. Deng, J. Guo, G. Ma, H. Zhang, D. Sun, Y. Hou et al.
Notes: Identifies a poor prognosis group
Meta‐analysis of the impact of surgical approach on the grade of mesorectal excision in rectal cancer. BJS 2017; 104: 1609-1619.
Authors: B. Creavin, M. E. Kelly, E. Ryan, D. C. Winter
Notes: Open excision provides better‐quality mesorectum